Endometriosis: Increasing concentrations of serum interleukin-1β and interleukin-1sRII is associated with the deep form of this pathology;Endométriose: L'augmentation des concentrations d'interleukine-1β et d'interleukine-1sRII dans le sérum est associée à la forme profonde de cette pathologie

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 43, Issue 9, 2014, Pages 735-743

  Lambert, S ^a   Santulli, P ^a,b   Chouzenoux, S ^a   Marcellin, L ^a,b   Borghese, B ^a,b   De Ziegler, D ^a   Batteux, F ^a   Chapron, C ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Cytokines; Endometriosis; IL 1sRII; Il 1 ; Pathogenesis; Serum

Indexed keywords

INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA; SOLUBLE INTERLEUKIN 1 RECEPTOR TYPE II; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOMETRIOSIS; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PATHOLOGY; PROSPECTIVE STUDY; ADULT; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY;

ADULT; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1BETA; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-1 TYPE II;

EID: 84910130391     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2014.06.014     Document Type: Article

References (33)

1. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99.
2. De Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010;376:730-8.
3. Rock JA, ZOLADEX Endometriosis Study Group. The revised American Fertility Society classification of endometriosis: reproducibility of scoring. Fertil Steril 1995;63:1108-10.
4. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie FJ. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991;55:759-65.
5. Chapron C, Fauconnier A, Vieira M, Barakat H, Dousset B, Pansini V, et al. Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Hum Reprod 2003;18:157-61.
6. Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-69.
7. Santulli P, Borghese B, Noël JC, Fayt I, Anaf V, de Ziegler D, et al. Hormonal therapy deregulates prostaglandin-endoperoxidase synthase 2 (PTGS2) expression in endometriotic tissues. J Clin Endocrinol Metab 2013.
8. Santulli P, Borghese B, Chouzenoux S, Vaiman D, Borderie D, Streuli I, et al. Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Hum Reprod 2012;27:2001-9.
9. Carmona F, Chapron C, Martínez-Zamora M-Á, Santulli P, Rabanal A, Martínez-Florensa M, et al. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol 2012;95:80-6.
10. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 2002;17:426-31.
11. Mahnke JL, Dawood MY, Huang JC. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 2000;73:166-70.
12. Sikora J, Mielczarek-Palacz A, Kondera-Anasz Z. Imbalance in cytokines from interleukin-1 family - role in pathogenesis of endometriosis. Am J Reprod Immunol 2012;68:138-45.
13. Zhang X, Lin J, Qian Y, Deng L. Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis. Fertil Steril 2004;81:1229-34.
14. Santulli P, Borghese B, Chouzenoux S, Streuli I, Borderie D, de Ziegler D, et al. Interleukin-19 and interleukin-22 serum levels are decreased in patients with ovarian endometrioma. Fertil Steril 2013;99:219-26.
15. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Chen HF, et al. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. Am J Obstet Gynecol 1996;175:1236-41.
16. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993;261:472-5.
17. Kondera-Anasz Z, Sikora J, Mielczarek-Palacz A, Jońca M. Concentrations of interleukin (IL)-1alpha IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol 2005;123:198-203.
18. Lawson C, Bourcier N, Al-Akoum M, Maheux R, Naud F, Akoum A. Abnormal interleukin 1 receptor types I and II gene expression in eutopic and ectopic endometrial tissues of women with endometriosis. J Reprod Immunol 2008;77:75-84.
19. Akoum A, Al-Akoum M, Lemay A, Maheux R, Leboeuf M. Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain. Fertil Steril 2008;89:1618-24.
20. Chapron C, Bourret A, Chopin N, Dousset B, Leconte M, Amsellem-Ouazana D, et al. Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions. Hum Reprod 2010;25:884-9.
21. Luisi S, Renner Stefan P, Santulli P. Endometrioma: from pathogenesis to clinical management. J Endometriosis 2013;5:91-9.
22. Fauconnier A, Chapron C, Dubuisson J-B, Vieira M, Dousset B, Bréart G. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril 2002;78:719-26.
23. Chapron C, Dubuisson J-B, Chopin N, Foulot H, Jacob S, Vieira M, et al. [Deep pelvic endometriosis: management and proposal for a "surgical classification"]. Gynecol Obstet Fertil 2003;31:197-206.
24. Chapron C, Chopin N, Borghese B, Foulot H, Dousset B, Vacher-Lavenu M-C, et al. Deeply infiltrating endometriosis: pathogenetic implications of the anatomical distribution. Hum Reprod 2006;21:1839-45.
25. Chopin N, Vieira M, Borghese B, Foulot H, Dousset B, Coste J, et al. Operative management of deeply infiltrating endometriosis: results on pelvic pain symptoms according to a surgical classification. J Minim Invasive Gynecol 2005;12:106-12.
26. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990;33:634-43.
27. Guilpain P, Servettaz A, Goulvestre C, Barrieu S, Borderie D, Chéreau C, et al. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis. Arthritis Rheum 2007;56:2455-63.
28. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45-51.
29. Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 1994;62:1086-8.
30. Senturk LM, Arici A. Immunology of endometriosis. J Reprod Immunol 1999;43:67-83.
31. Kharfi A, Akoum A. Soluble interleukin-1 receptor type II blocks monocyte chemotactic protein-1 secretion by U937 cells in response to peripheral blood serum of women with endometriosis. Fertil Steril 2002;78:836-42.
32. Bossù P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, et al. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol 1995;147:1852-61.
33. Kalu E, Sumar N, Giannopoulos T, Patel P, Croucher C, Sherriff E, et al. Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J Obstet Gynaecol Res 2007;33:490-5.